Agonist and Inverse Agonist Actions of β-Blockers at the Human β2-Adrenoceptor Provide Evidence for Agonist-Directed SignalingJillian G. Baker, Stephen J. Hill, Ian P. Hall|Molecular Pharmacology|2003Cited by 187
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signallingJillian G. Baker, Roger J. Summers, Stephen J. Hill|Trends in Pharmacological Sciences|2011Cited by 134
Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimatesJillian G. Baker, Stephen J. Hill|Trends in Pharmacological Sciences|2007Cited by 114
Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A<sub>1</sub> receptor ligandsJillian G. Baker, Stephen J. Hill, Luke A. Adams et al.|British Journal of Pharmacology|2010Cited by 94
Agonist Actions of “β-Blockers” Provide Evidence for Two Agonist Activation Sites or Conformations of the Human β1-AdrenoceptorJillian G. Baker, Stephen J. Hill, Ian P. Hall|Molecular Pharmacology|2003Cited by 91